DNA methylation-based classification of central nervous system tumours
2018/03/13 by David Capper, David Jones, David T. W. Jones +155 · 3,177 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Biology #Cancer Genomics and Diagnostics #Central nervous system #Computational biology #DNA #DNA methylation #Epigenetics and DNA Methylation #Gene #Genetics #Glioma Diagnosis and Treatment #Methylation #Nervous system #Neuroscience
paper · open access · doi:10.1038/nature26000
published in Nature 555(7697), 469-474 (Nature Portfolio)
openalex publication_date 2018/03/13 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/06
Citations
Cited by
- Ultra-fast deep-learned CNS tumour classification during surgery
- Proneural–mesenchymal hybrid glioblastoma cells are resistant to therapy and dependent on nuclear import
- DNA methylation analysis reveals an epigenetic signature distinctive of high-grade oligodendroglioma
- Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standard
- Epigenetic age acceleration is associated with oligodendrocyte proportions in MSA and control brain tissue
- The Epigenetic Hallmarks of Cancer
- Digital Biopsy and Network Analysis of Dynamic [ 68 Ga]Ga-FAPI-46 Data in Patients with Malignant and Benign Pancreatic Lesions
- Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability
- Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM
- Computational Methods for Data Integration and Imputation of Missing Values in Omics Datasets
- Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas
- Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas
- FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma
- DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasms
- Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes
- Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors
- Combining Machine Learning and Computational Chemistry for Predictive Insights Into Chemical Systems
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- Intelligence, physics and information -- the tradeoff between accuracy and simplicity in machine learning
- ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumor diagnosis
- Human-Expert-Level Brain Tumor Detection Using Deep Learning with Data Distillation and Augmentation
- Histology and spatial transcriptomic integration revealed infiltration zone with specific cell composition as a prognostic hotspot in glioblastoma
- Artificial Intelligence for the Diagnosis and Management of Cancers: Potentials and Challenges
- A ternary-code DNA methylome atlas of mouse tissues
- The prognostic impact of CDKN2A/B hemizygous deletions in meningioma
- Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial
- Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort
- cIMPACT-NOW Update 12: Refining pathology-based risk stratification and grading for IDH-mutant gliomas
- A novel model of glioblastoma recurrence to identify therapeutic vulnerabilities
- Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics
- Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma
- Accurate calling of KIAA1549‐BRAF fusions from DNA of human brain tumours using methylation array‐based copy number and gene panel sequencing data
- Inflammasome Dynamics in Psoriasis: AIM2, NLRP3, and NLRP1 at the Interface of Inflammation and Immunity
- Multi-omics strategies for biomarker discovery and application in personalized oncology
- A scalable Tn5-based method for genome-wide DNA methylation profiling in development and disease
- Comparison of Fluorescence In Situ Hybridization, Next-Generation Sequencing, and DNA Methylation Microarray for Copy Number Variation Assessment in Gliomas
- Intraoperative DNA methylation classification of brain tumors impacts neurosurgical strategy
- Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
- Accounting for diversity in AI for medicine
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
- Soft tissue pathology for the radiologist: a tumor board primer with 2020 WHO classification update
- Artificial Intelligence in Cancer Research and Precision Medicine
- Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases
- Prediction of Cancer Microarray and DNA Methylation Data using Non-negative Matrix Factorization
- A new direction to promote the implementation of artificial intelligence in natural clinical settings
- Artificial intelligence in cancer pathology: Applications, challenges, and future directions
- cIMPACT ‐ NOW update 11: Proposal on adaptation of diagnostic criteria for IDH ‐ and H3 ‐wildtype diffuse high‐grade gliomas and for posterior fossa ependymal tumors
- Accurate Prediction of Central Conventional Chondrosarcoma Risk and Outcome Using Methylation Profiling: CHROME
- Integration of omics data in the diagnosis and therapy of glioblastoma
- OmiEmbed: A Unified Multi-Task Deep Learning Framework for Multi-Omics Data
- Imaging Characteristics of CNS Neuroblastoma-FOXR2: A Retrospective and Multi-Institutional Description of 25 Cases
- Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. [europepmc]
- cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV". [europepmc]
- Challenges to curing primary brain tumours. [europepmc]
- Childhood cerebellar tumours mirror conserved fetal transcriptional programs. [europepmc]
- Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. [europepmc]
- Genetic and molecular epidemiology of adult diffuse glioma. [europepmc]
- Resolving medulloblastoma cellular architecture by single-cell genomics. [europepmc]
- EANO guideline on the diagnosis and treatment of vestibular schwannoma. [europepmc]
- DNA Methylation Cancer Biomarkers: Translation to the Clinic. [europepmc]
- cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. [europepmc]
- Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. [europepmc]
- Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics. [europepmc]
- Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer. [europepmc]
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. [europepmc]
- Sarcoma classification by DNA methylation profiling. [europepmc]
- Proteogenomic and metabolomic characterization of human glioblastoma. [europepmc]
- A vaccine targeting mutant IDH1 in newly diagnosed glioma. [europepmc]
- Artificial Intelligence in Cancer Research and Precision Medicine. [europepmc]
- Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. [europepmc]
- Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. [europepmc]
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. [europepmc]
- Combining Machine Learning and Computational Chemistry for Predictive Insights Into Chemical Systems. [europepmc]
- A clinically applicable integrative molecular classification of meningiomas. [europepmc]
- Glioma targeted therapy: insight into future of molecular approaches. [europepmc]
- Glioblastoma and Other Primary Brain Malignancies in Adults: A Review. [europepmc]